BIOTECH · A new cancer pill won FDA approval. Patients can't get it
Rasonque treats a genetic driver of pancreatic cancer, but insurance delays are leaving newly-approved patients stuck for weeks, STAT found.

BIOTECH · A new cancer pill won FDA approval. Patients can't get it
Rasonque treats a genetic driver of pancreatic cancer, but insurance delays are leaving newly-approved patients stuck for weeks, STAT found.